| Date Filed | Type | Description |
| 10/03/2023 |
4
| Olivo Alicia C (General Counsel) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Paid exercise price by delivering 14 shares
@ $0 |
|
| 08/14/2023 |
4
| Perez David Brian (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 08/14/2023 |
4
| Zook Anthony P. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 08/14/2023 |
4
| HANNAH ALISON L. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 08/14/2023 |
4
| Kelly Michael Aaron (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 08/14/2023 |
4
| KANOVSKY STEPHEN M (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 08/14/2023 |
4
| CROWTHER BRUCE K (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 08/14/2023 |
4
| TETRAULT LYNN A. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 08/14/2023 |
4
| Floegel Elizabeth (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 08/14/2023 |
4
| Gunn Neil (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 8,353 options to buy
@ $14.82, valued at
$123.8k
Granted 11,336 restricted stock units
@ $0 |
|
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/06/2023 |
3
| Floegel Elizabeth (Director) has filed a Form 3 on NEOGENOMICS INC |
| 07/06/2023 |
3
| Zook Anthony P. (Director) has filed a Form 3 on NEOGENOMICS INC |
| 06/29/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/02/2023 |
4
| Sikri Vishal (President Advanced Diagnostics) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Paid exercise price by delivering 21,406 shares
@ $0 |
|
| 06/01/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/30/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/24/2023 |
3
| Aunan Greg D (Chief Accounting Officer) has filed a Form 3 on NEOGENOMICS INC |
| 05/24/2023 |
4
| TETRAULT LYNN A. (Director) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Exercised 1,507 options to buy
@ $11.6, valued at
$17.5k
|
|
| 05/17/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/15/2023 |
4
| Smith Christopher M (CEO) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 269,841 options to buy
@ $19.65, valued at
$5.3M
Granted 144,190 restricted stock units
@ $0
Granted 144,190 rights
@ $0 |
|
| 05/15/2023 |
4
| Sherman Jeffrey Scott (CFO) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 73,016 options to buy
@ $19.65, valued at
$1.4M
Granted 39,016 restricted stock units
@ $0
Granted 39,016 rights
@ $0 |
|
| 05/15/2023 |
4
| Stone Warren (President, Clinical Services) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 53,969 options to buy
@ $19.65, valued at
$1.1M
Granted 28,838 restricted stock units
@ $0
Granted 21,204 rights
@ $0 |
|
| 05/15/2023 |
4
| Sikri Vishal (President Advanced Diagnostics) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 39,683 options to buy
@ $19.65, valued at
$779.8k
Granted 21,204 restricted stock units
@ $0
Granted 21,204 rights
@ $0 |
|
| 05/15/2023 |
4
| Harris Melody (President, Enterprise Ops) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 39,683 options to buy
@ $19.65, valued at
$779.8k
Granted 21,204 restricted stock units
@ $0
Granted 21,204 rights
@ $0 |
|
| 05/15/2023 |
4
| Olivo Alicia C (General Counsel) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Granted 36,508 options to buy
@ $19.65, valued at
$717.4k
Granted 19,508 restricted stock units
@ $0
Granted 19,508 rights
@ $0 |
|
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/08/2023 |
8-K
| Quarterly results |
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2023 |
4
| Kulkarni Shashikant (Chief Scientific Officer) has filed a Form 4 on NEOGENOMICS INC|
Txns:
| Paid exercise price by delivering 3,759 shares
@ $0 |
|
| 04/04/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
|